U.S. markets closed
  • S&P Futures

    4,167.75
    +10.00 (+0.24%)
     
  • Dow Futures

    34,353.00
    +97.00 (+0.28%)
     
  • Nasdaq Futures

    13,346.50
    +43.00 (+0.32%)
     
  • Russell 2000 Futures

    2,232.50
    +7.00 (+0.31%)
     
  • Crude Oil

    66.33
    +0.06 (+0.09%)
     
  • Gold

    1,870.90
    +3.30 (+0.18%)
     
  • Silver

    28.66
    +0.38 (+1.35%)
     
  • EUR/USD

    1.2167
    +0.0010 (+0.09%)
     
  • 10-Yr Bond

    1.6400
    +0.0050 (+0.31%)
     
  • Vix

    19.72
    +0.91 (+4.84%)
     
  • GBP/USD

    1.4169
    +0.0032 (+0.23%)
     
  • USD/JPY

    109.1830
    -0.0170 (-0.02%)
     
  • BTC-USD

    44,993.86
    +497.77 (+1.12%)
     
  • CMC Crypto 200

    1,242.04
    +44.13 (+3.68%)
     
  • FTSE 100

    7,032.85
    -10.76 (-0.15%)
     
  • Nikkei 225

    28,402.64
    +577.81 (+2.08%)
     

Teladoc Shareholders Worried About Post-Pandemic Blues, But It's Amwell That's Seeing the Slowdown

Nicholas Rossolillo, The Motley Fool
·4 min read
Teladoc Shareholders Worried About Post-Pandemic Blues, But It's Amwell That's Seeing the Slowdown
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Telemedicine pioneer Teladoc Health (NYSE: TDOC) had an incredible 2020. The pandemic turned the small but growing remote virtual care niche of the healthcare industry into a basic staple. Helped by its transformational acquisition of Livongo Health last autumn, Teladoc has dispelled those fears with an outlook for revenue to nearly double again in 2021.